Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease

被引：4

作者：

Bhattacharya, Soumee ^{[1
]}

Montag, Dirk ^{[1
]}

机构：

[1] Leibniz Inst Neurobiol, Neurogenet Special Lab, Magdeburg, Germany

来源：

NEURAL REGENERATION RESEARCH | 2015年 / 10卷 / 01期

关键词：

GALANTAMINE; EFFICACY;

D O I：

10.4103/1673-5374.150648

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：43 / 45

页数：3

共 50 条

[1] Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease
Soumee Bhattacharya
Dirk Montag
Neural Regeneration Research, 2015, (01) : 43 - 45
[2] Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease
White, CM
Dicks, RS
FORMULARY, 1999, 34 (06) : 493 - +
[3] Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor
Mimori, Y
Nakamura, S
Yukawa, M
BEHAVIOURAL BRAIN RESEARCH, 1997, 83 (1-2) : 25 - 30
[4] Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease
Lanctôt, KL
Herrmann, N
LouLou, MM
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (01): : 13 - 26
[5] Xanthone: Potential Acetylcholinesterase Inhibitor for Alzheimer's Disease Treatment
Vanessa, Vincentsia Vienna
Mah, Siau Hui
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (17) : 2507 - 2529
[6] Race differences in acetylcholinesterase inhibitor use for Alzheimer's disease
Mehta, KM
Yin, M
Resendez, C
Yaffe, K
NEUROLOGY, 2005, 64 (06) : A317 - A317
[7] Bilingualism as a strategy to delay the onset of Alzheimer's disease
Klimova, Blanka
Valis, Martin
Kuca, Kamil
CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 1731 - 1737
[8] Acetylcholinesterase inhibitor treatment for Alzheimer's disease: the experience in Picardy.
Magnier, V
Flipon, E
Godefroy, O
Ganry, O
Dupuy-Sonntag, D
Rosa, A
REVUE NEUROLOGIQUE, 2005, 161 (02) : 211 - 213
[9] Focus on donepezil: A reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease
Rho, JP
Lipson, LG
FORMULARY, 1997, 32 (07) : 677 - &
[10] Chemical synthesis of galantamine, an acetylcholinesterase inhibitor for treatment of Alzheimer's disease
Marco-Contelles, J
Rodriguez, C
García, AG
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) : 575 - 587

← 1 2 3 4 5 →